cit-013
Biologicalexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2024 (NCT06567470)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- H4INHIBITOR
H4 inhibitor
- Histone H2A.JINHIBITOR
H2AJ inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06993233 | Phase 2 | Oct 31, 2025 | Citryll BV |
| NCT06567470 | Phase 2 | Nov 30, 2024 | Citryll BV |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Citryll BV | For profit | 2 | 2 | 1 | 2024 |
1 organizations
Page 1 / 1